Back
Cullinan Therapeutics Vs. Fate Therapeutics Industry Stock Comparison
Sell
42
CGEM
Cullinan Therapeutics
Last Price:
23.50
Seasonality Move:
5.46%
Sell
50
FATE
Fate Therapeutics
Last Price:
3.70
Seasonality Move:
-0.85%
Sell
42
Cullinan Therapeutics (CGEM)
is a Sell
Is Cullinan Therapeutics a Buy, Sell or Hold?
- The current Cullinan Therapeutics [CGEM] share price is $23.49. The Score for CGEM is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CGEM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Fate Therapeutics (FATE)
is a Sell
Is Fate Therapeutics a Buy, Sell or Hold?
- The current Fate Therapeutics [FATE] share price is $3.68. The Score for FATE is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- FATE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CGEM Stock Price Chart
What is Cullinan Therapeutics's stock price today?
-
The Cullinan Therapeutics share price today is $23.49
The current trend is relatively stagnant and CGEM is experiencing buying pressure, which is a positive indicator for future bullish movement.
FATE Stock Price Chart
What is Fate Therapeutics's stock price today?
-
The Fate Therapeutics share price today is $3.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing buying pressure, which is a positive indicator for future bullish movement.
CGEM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 50.35 | Buy |
Chaikin Money Flow: | 317065 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.37 - 27.67) | Sell |
Bollinger Bands (100): | (13.89 - 23.21) | Buy |
FATE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 38.57 | Sell |
Chaikin Money Flow: | 1388419 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.61 - 4.13) | Sell |
Bollinger Bands (100): | (4.2 - 7.1) | Sell |
CGEM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.13 | Buy |
20-day SMA: | 25.14 | Sell |
50-day SMA: | 21.32 | Buy |
200-day SMA: | 13.98 | Buy |
8-day EMA: | 23.39 | Buy |
20-day EMA: | 23.73 | Sell |
50-day EMA: | 21.91 | Buy |
200-day EMA: | 16.08 | Buy |
FATE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.55 | Buy |
20-day SMA: | 3.84 | Sell |
50-day SMA: | 4.98 | Sell |
200-day SMA: | 4.06 | Sell |
8-day EMA: | 3.61 | Buy |
20-day EMA: | 3.89 | Sell |
50-day EMA: | 4.62 | Sell |
200-day EMA: | 5.36 | Sell |
Cullinan Therapeutics Earnings Growth & CGEM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.86 per share, and a decrease next year of $0.13 per share.
Fate Therapeutics Earnings Growth & FATE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.11 per share, and an increase next year of $0.07 per share.
Cullinan Therapeutics Technical Analysis
May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Fate Therapeutics Technical Analysis
May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |